Home Cart 0 Sign in  

[ CAS No. 32955-22-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 32955-22-9
Chemical Structure| 32955-22-9
Structure of 32955-22-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 32955-22-9 ]

Related Doc. of [ 32955-22-9 ]

Alternatived Products of [ 32955-22-9 ]

Product Details of [ 32955-22-9 ]

CAS No. :32955-22-9 MDL No. :MFCD06205069
Formula : C6H7NO2S Boiling Point : -
Linear Structure Formula :- InChI Key :CIPMPQGRFNDLAP-UHFFFAOYSA-N
M.W : 157.19 Pubchem ID :459108
Synonyms :

Calculated chemistry of [ 32955-22-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.2
TPSA : 67.43 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.93
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.32
Log Po/w (MLOGP) : 0.02
Log Po/w (SILICOS-IT) : 2.19
Consensus Log Po/w : 1.39

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.94
Solubility : 1.81 mg/ml ; 0.0115 mol/l
Class : Very soluble
Log S (Ali) : -2.53
Solubility : 0.459 mg/ml ; 0.00292 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.76
Solubility : 2.72 mg/ml ; 0.0173 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.17

Safety of [ 32955-22-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 32955-22-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 32955-22-9 ]
  • Downstream synthetic route of [ 32955-22-9 ]

[ 32955-22-9 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 32955-22-9 ]
  • [ 38585-74-9 ]
YieldReaction ConditionsOperation in experiment
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate C.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (2.89 g, 76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 minutes.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent -2percent -4percent methanol in chloroform, to provide the desired compound, Rf-0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3) δ4.92 (s, 2H), 7.78 (s, 1H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate P.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the flitrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent -2percent-4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3)δ4.92
(s, 2H), 7.78 (s, 1H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate K.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent - 2percent - 4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3) δ4.92 (s, 2H), 7.78 (s, 1 H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate K.
5-(Hydroxymethyl)thiazole.
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol) in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two filtrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent-2percent-4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield. NMR (CDCl3) δ4.92
(s, 2H), 7.78 (s, 1H), 8.77 (s, 1H).
Mass spectrum: (M+H)+ =116.
75% With sodium hydroxide In tetrahydrofuran; methanol; chloroform; water; ethyl acetate D.
5-(Hydroxymethyl)thiazole
To a precooled (ice bath) three neck 500 mL flask containing lithium aluminum hydride (76 mmol) in 250 mL of THF was added ethyl thiazole-5-carboxylate (11.82 g, 75.68 mmol)in 100 mL of THF dropwise over 1.5 hours to avoid excess foaming.
The reaction was stirred for an additional hour, and treated cautiously with 2.9 mL of water, 2.9 mL of 15percent NaOH, and 8.7 mL of water.
The solid salts were filtered, and the filtrate set aside.
The crude salts were heated at reflux in 100 mL of ethyl acetate for 30 min.
The resulting mixture was filtered, and the two flitrates were combined, dried over Na2 SO4, and concentrated in vacuo.
The product was purified by silica gel chromatography eluding sequentially with 0percent-2percent-4percent methanol in chloroform, to provide the desired compound, Rf=0.3 (4percent methanol in chloroform), which solidified upon standing in 75percent yield.
NMR (CDCl3) δ4.92 (s, 2 H), 7.78 (s, 1 H), 8.77 (s, 1 H).
Mass spectrum: (M+H)+ =116.

Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 7, p. 3124 - 3153
[2] Journal of Medicinal Chemistry, 1998, vol. 41, # 4, p. 602 - 617
[3] Patent: US5914332, 1999, A,
[4] Patent: US5455351, 1995, A,
[5] Patent: US5559158, 1996, A,
[6] Patent: US5484801, 1996, A,
[7] Patent: US5461067, 1995, A,
[8] Patent: EP1170289, 2002, A2, . Location in patent: Page 44-45
[9] Helvetica Chimica Acta, 1952, vol. 35, p. 215
[10] Journal of Medicinal Chemistry, 1973, vol. 16, p. 978 - 984
[11] Patent: US5559158, 1996, A,
[12] Patent: US5484801, 1996, A,
  • 2
  • [ 32955-22-9 ]
  • [ 14527-41-4 ]
YieldReaction ConditionsOperation in experiment
57% With hydrogenchloride; sodium hydroxide In ethanol The 5-[α-hydroxy-3-(naphth-2-ylmethoxy)benzyl]thiazole used as a starting material was obtained as follows:
A mixture of ethyl thiazole-5-carboxylate (8.5 g), 2N sodium hydroxide solution (28 ml) and ethanol (50 ml) was stirred at ambient temperature for 2.5 hours.
The mixture was concentrated and partitioned between diethyl ether and water.
The aqueous layer was acidified by the addition of 2N hydrochloric acid solution and extracted with methylene chloride (6*50 ml).
The combined extracts were dried (MgSO4) and evaporated to give thiazole-5-carboxylic acid (4 g, 57percent), m.p. 214°-216° C.
Reference: [1] Patent: US5089513, 1992, A,
  • 3
  • [ 32955-22-9 ]
  • [ 14527-41-4 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1953, vol. 72, p. 262,267
[2] Helvetica Chimica Acta, 1942, vol. 25, p. 375
[3] Journal of Physical Chemistry, 1948, vol. 52, p. 729,736, 737
[4] Journal of Chemical Research, 2011, vol. 35, # 5, p. 313 - 316
  • 4
  • [ 3034-55-7 ]
  • [ 64-17-5 ]
  • [ 201230-82-2 ]
  • [ 32955-22-9 ]
Reference: [1] Tetrahedron Letters, 1984, vol. 25, # 51, p. 5939 - 5942
  • 5
  • [ 115-08-2 ]
  • [ 33142-21-1 ]
  • [ 32955-22-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 4, p. 602 - 617
[2] Patent: EP1170289, 2002, A2, . Location in patent: Page 44
[3] Yakugaku Zasshi, 1953, vol. 73, p. 126[4] Chem.Abstr., 1953, p. 12358
[5] Journal of Medicinal and Pharmaceutical Chemistry, 1959, vol. 1, p. 577,594
[6] Recueil des Travaux Chimiques des Pays-Bas, 1953, vol. 72, p. 262,267
[7] Helvetica Chimica Acta, 1937, vol. 20, p. 204
[8] Patent: US5914332, 1999, A,
[9] Patent: US5455351, 1995, A,
[10] Patent: US5559158, 1996, A,
[11] Patent: US5484801, 1996, A,
[12] Patent: US5461067, 1995, A,
[13] Journal of Chemical Research, 2011, vol. 35, # 5, p. 313 - 316
  • 6
  • [ 32955-21-8 ]
  • [ 110-46-3 ]
  • [ 32955-22-9 ]
Reference: [1] Patent: US5484801, 1996, A,
[2] Patent: US5559158, 1996, A,
  • 7
  • [ 77287-34-4 ]
  • [ 33142-21-1 ]
  • [ 32955-22-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 7, p. 3124 - 3153
  • 8
  • [ 188290-36-0 ]
  • [ 83553-48-4 ]
  • [ 32955-22-9 ]
  • [ 1240399-14-7 ]
Reference: [1] European Journal of Organic Chemistry, 2010, # 18, p. 3416 - 3427
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 32955-22-9 ]

Ritonavir Related Intermediates

Chemical Structure| 144163-97-3

[ 144163-97-3 ]

4-Nitrophenyl (thiazol-5-ylmethyl) carbonate

Chemical Structure| 154212-60-9

[ 154212-60-9 ]

2-Isopropyl-4-(methylaminomethyl)thiazole

Chemical Structure| 6306-52-1

[ 6306-52-1 ]

H-Val-OMe.HCl

Chemical Structure| 38585-74-9

[ 38585-74-9 ]

Thiazol-5-ylmethanol

Chemical Structure| 3182-95-4

[ 3182-95-4 ]

(S)-2-Amino-3-phenylpropan-1-ol

Related Functional Groups of
[ 32955-22-9 ]

Esters

Chemical Structure| 14527-44-7

[ 14527-44-7 ]

Methyl thiazole-5-carboxylate

Similarity: 0.96

Chemical Structure| 79836-78-5

[ 79836-78-5 ]

Ethyl 2-methylthiazole-5-carboxylate

Similarity: 0.89

Chemical Structure| 152300-59-9

[ 152300-59-9 ]

Ethyl 4-aminothiazole-5-carboxylate

Similarity: 0.89

Chemical Structure| 32955-21-8

[ 32955-21-8 ]

Ethyl 2-aminothiazole-5-carboxylate

Similarity: 0.86

Chemical Structure| 278183-10-1

[ 278183-10-1 ]

Methyl 4-amino-5-thiazolecarboxylate

Similarity: 0.86

Related Parent Nucleus of
[ 32955-22-9 ]

Thiazoles

Chemical Structure| 14527-44-7

[ 14527-44-7 ]

Methyl thiazole-5-carboxylate

Similarity: 0.96

Chemical Structure| 14527-41-4

[ 14527-41-4 ]

5-Thiazolecarboxylic acid

Similarity: 0.91

Chemical Structure| 79836-78-5

[ 79836-78-5 ]

Ethyl 2-methylthiazole-5-carboxylate

Similarity: 0.89

Chemical Structure| 152300-59-9

[ 152300-59-9 ]

Ethyl 4-aminothiazole-5-carboxylate

Similarity: 0.89

Chemical Structure| 32955-21-8

[ 32955-21-8 ]

Ethyl 2-aminothiazole-5-carboxylate

Similarity: 0.86